Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
About this item
Full title
Author / Creator
Publisher
New York: Nature Publishing Group US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Nature Publishing Group US
Subjects
More information
Scope and Contents
Contents
Patients with sickle cell disease or β-thalassemia are treated with drugs that aim to reactivate production of fetal hemoglobin, but these drugs are not effective in all patients and have side effects. Lihong Shi
et al
. identify a new therapeutic strategy for these anemias, showing that a drug used to treat depression, tranylcypromine, can r...
Alternative Titles
Full title
Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5512162
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5512162
Other Identifiers
ISSN
1078-8956
E-ISSN
1546-170X
DOI
10.1038/nm.3101
